Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [31] Pediatric Off-label Use of Recombinant Factor VIIa
    Alten, Jeffrey A.
    Benner, Kim
    Green, Kelsey
    Toole, Benjamin
    Tofil, Nancy M.
    Winkler, Margaret K.
    PEDIATRICS, 2009, 123 (03) : 1066 - 1072
  • [32] Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery
    Al-Ruzzeh, Sharif
    Ibrahim, Khalid
    Navia, Jose L.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2008, 22 (05) : 783 - 785
  • [33] The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome
    Faber, P.
    Craig, W. L.
    Duncan, J. L.
    Holliday, K.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2007, 51 (09) : 1277 - 1279
  • [34] Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa
    Winch, Peter D.
    Naguib, Aymen N.
    Bradshaw, Jacob R.
    Galantowicz, Mark
    Tobias, Joseph D.
    PEDIATRIC CARDIOLOGY, 2013, 34 (01) : 119 - 124
  • [35] Off-Label Use of Recombinant Factor VIIa in Pediatric Patients
    McQuilten, Zoe K.
    Barnes, Chris
    Zatta, Amanda
    Phillips, Louise E.
    PEDIATRICS, 2012, 129 (06) : E1533 - E1540
  • [36] Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy
    Berrin Gunaydin
    Zerrin Ozkose
    Seyda Pezek
    Journal of Anesthesia, 2007, 21 : 106 - 107
  • [37] Use of recombinant factor VIIa for major elective surgery in a patient with factor VII deficiency, retroperitoneal fibrosis and hydronephrosis
    Cobos, E
    Keung, YKK
    Akhter, S
    Jones, J
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1997, 3 (01) : 33 - 35
  • [38] Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery
    Al-Said, Khoula
    Anderson, Ronald
    Wong, Andrew
    Le, Doan
    JOURNAL OF PEDIATRIC SURGERY, 2008, 43 (04) : e15 - e19
  • [39] Use of recombinant factor VIIa during excision of vascular anomalies
    Buckmiller, Lisa M.
    Richter, Gresham T.
    Waner, Milton
    Suen, James Y.
    LARYNGOSCOPE, 2007, 117 (04) : 604 - 609
  • [40] Therapy-resistant haemarthros in a patient with factor VIII inhibitor: successful treatment with recombinant factor VIIa
    E. Lenz
    M. Repas-Humpe
    J. Oldenburg
    W. Kreuz
    W. Schröter
    S. W. Eber
    European Journal of Pediatrics, 1999, 158 : 951 - 952
12345